Showing results (1-10 of 117) with videos related to
Sort By:
Pageof 12
Expert Opinion on Biological Therapy|April 15, 2008
Immunological reconstitution after hematopoietic cell transplantation - its relation to the contents of the graftJan StorekBest Practice & Research. Clinical Haematology|April 24, 2007
Immune reconstitution following hematopoietic stem-cell transplantationMichelle Geddes, Jan StorekBone Marrow Transplantation|November 24, 2023
Rituximab for posttransplant lymphoproliferative disorder - therapeutic, preemptive, or prophylactic?Jan Storek, Julian LindsayFrontiers in Oncology|February 6, 2023
The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A reviewRobert Puckrin, Mona Shafey, Jan StorekActa Haematologica|November 23, 2023
Complete Response to Donor Lymphocyte Infusion for Primary Hemophagocytic Lymphohistiocytosis Relapse after Allogeneic Hematopoietic Cell TransplantationRutvij A Khanolkar, Nathan Kuehne, Jan StorekBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 9, 2014
Rabbit anti-T cell globulin in allogeneic hematopoietic cell transplantationJan Storek, Mohamad Mohty, Jaap Jan BoelensCurrent Opinion in Hematology|April 21, 2012
Immune reconstitution after hematopoietic cell transplantationMark Bosch, Faisal M Khan, Jan StorekBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2003
Correlation between the numbers of naive T cells infused with blood stem cell allografts and the counts of naive T cells after transplantationJan Storek, Monja A Dawson, David G MaloneyFrontiers in Medicine|March 14, 2022
Case Report: Chemotherapy-Associated Systemic Sclerosis: Is DNA Damage to Blame?Amy X Du, Robert Gniadecki, Jan Storek, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 16, 2017
Incidence and risk factor of hemorrhagic cystitis after allogeneic transplantation with fludarabine, busulfan, and anti-thymocyte globulin myeloablative conditioningWilson Lam, Jan Storek, Haocheng Li, et al.Pageof 12